Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis
Cerda-Fuertes N.; Nagy S.; Schaedelin S.; Sinnecker T.; Ruberte E.; Papadopoulou A.; Wurfel J.; Kuhle J.; Yaldizli O.; Kappos L.; Derfuss T.; Decard B.F.. Therapeutic advances in neurological disorders. 2023.Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination.
Ayroza Galvão Ribeiro Gomes AB; Kulsvehagen L; Lipps P; Cagol A; Cerdá-Fuertes N; Neziraj T; Flammer J; Lerner J; Lecourt AC; de Oliveira S Siebenborn N; Cortese R; Schaedelin S; Andreoli Schoeps V; de Moura Brasil Matos A; Trombini Mendes N; Dos Reis Pereira C; Ribeiro Monteiro ML; Dos Apóstolos-Pereira SL; Schindler P; Chien C; Schwake C; Schneider R; Pakeerathan T; Aktas O; Fischer U; Mehling M; Derfuss T; Kappos L; Ayzenberg I; Ringelstein M; Paul F; Callegaro D; Kuhle J; Papadopoulou A; Granziera C; Pröbstel AK. JAMA neurology. 2023.Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol A; Fuertes NC; Stoessel M; Barakovic M; Schaedelin S; D'Souza M; Würfel J; Brandt AU; Kappos L; Sprenger T; Naegelin Y; Kuhle J; Granziera C; Papadopoulou A. Journal of Neurology. 2023.Longitudinal changes of deep gray matter shape in multiple sclerosis.
Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S. NeuroImage. Clinical. 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.MRI with Contrast Agent Showing Arterial Wall Inflammation in Giant Cell Arteritis
Anastasiou A; Rusche N; Blackham KA; Papadopoulou A. . 2022.Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.
Kenney R; Liu M; Hasanaj L; Joseph B; Al-Hassan AA; Balk L; Behbehani R; Brandt AU; Calabresi PA; Frohman EM; Frohman T; Havla J; Hemmer B; Jiang H; Knier B; Korn T; Leocani L; Martínez-Lapiscina EH; Papadopoulou A; Paul F; Petzold A; Pisa M; Villoslada P; Zimmermann H; Ishikawa H; Schuman JS; Wollstein G; Chen Y; Saidha S; Thorpe LE; Galetta SL; Balcer LJ; IMSVISUAL Consortium. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2022.S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal.
Stamatellos VP; Rigas A; Stamoula E; Lallas A; Papadopoulou A; Papazisis G. Multiple Sclerosis and Related Disorders. 2022.The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.
Kenney RC; Liu M; Hasanaj L; Joseph B; Abu Al-Hassan A; Balk LJ; Behbehani R; Brandt A; Calabresi PA; Frohman E; Frohman TC; Havla J; Hemmer B; Jiang H; Knier B; Korn T; Leocani L; Martinez-Lapiscina EH; Papadopoulou A; Paul F; Petzold A; Pisa M; Villoslada P; Zimmermann H; Thorpe LE; Ishikawa H; Schuman JS; Wollstein G; Chen Y; Saidha S; Galetta S; Balcer LJ. Neurology. 2022.Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K. European Journal of Neurology. 2021.Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance.
Tsagkas C; Parmar K; Pezold S; Barro C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Papadopoulou A; Wuerfel J; Kappos L; Kuhle J; Sprenger T; Granziera C; Magon S. Human Brain Mapping. 2021.Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis.
Lin TY; Vitkova V; Asseyer S; Martorell Serra I; Motamedi S; Chien C; Ditzhaus M; Papadopoulou A; Benkert P; Kuhle J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU; Zimmermann HG. Neurology(R) neuroimmunology & neuroinflammation. 2021.Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study.
Papadopoulou A; Oertel FC; Chien C; Kuchling J; Zimmermann HG; Siebert N; Motamedi S; Souza M; Asseyer S; Bellmann-Strobl J; Ruprecht K; Chakravarty MM; Scheel M; Magon S; Wuerfel J; Paul F; Brandt AU. NeuroImage. Clinical. 2021.Standardization and digitization of clinical data in multiple sclerosis.
D'Souza M; Papadopoulou A; Girardey C; Kappos L. Nature reviews. Neurology. 2021.Advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Derfuss T; Mehling M; Papadopoulou A; Bar-Or A; Cohen JA; Kappos L. The Lancet Neurology. 2020.Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: Results of an international survey.
D'Souza M; Papadopoulou A; Levy M; Jacob A; Yeaman MR; Kümpfel T; Marignier R; Paul F; Brandt AU. Multiple Sclerosis and Related Disorders. 2020.Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.
Zuber P; Tsagkas C; Papadopoulou A; Gaetano L; Huerbin M; Geiter E; Altermatt A; Parmar K; Ettlin T; Schuster-Amft C; Suica Z; Alrasheed H; Wuerfel J; Kesselring J; Kappos L; Sprenger T; Magon S. Journal of Neurology. 2020.Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.
D'Souza M; Heikkilä A; Lorscheider J; Haller V; Kravalis K; Gysin S; Fuertes NAC; Fricker E; Lam E; Higgins P; Tomic D; Papadopoulou A; Kappos L. Multiple sclerosis (Houndmills, Basingstoke, England). 2020.Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.
Gkaniatsou T; Papadopoulou A; Paul F; Brandt AU; Oertel FC. ACTA NEUROLOGICA BELGICA. 2020.Isolated oculomotor palsy due to acute ischemic midbrain stroke.
Kronlage C; Papadopoulou A; De Marchis GM. ACTA NEUROLOGICA BELGICA. 2020.Longitudinal patterns of cortical thinning in multiple sclerosis.
Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S. Human Brain Mapping. 2020.Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
Juenger V; Cooper G; Chien C; Chikermane M; Oertel FC; Zimmermann H; Ruprecht K; Jarius S; Siebert N; Kuchling J; Papadopoulou A; Asseyer S; Bellmann-Strobl J; Paul F; Brandt AU; Scheel M. European Radiology. 2020.Short timescale modulation of cortical and cerebellar activity in the early phase of motor sequence learning: an fMRI study
Magon S.; Pfister A.; Laura G.; Luthi M.; Papadopoulou A.; Kappos L.; Sprenger T.. Brain imaging and behavior. 2020.Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer S; Kuchling J; Gaetano L; Komnenić D; Siebert N; Chien C; Scheel M; Oertel FC; Ruprecht K; Bellmann-Strobl J; Finke C; Chakravarty MM; Magon S; Wuerfel J; Paul F; Papadopoulou A; Brandt AU. Multiple Sclerosis and Related Disorders. 2020.Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T. Journal of Neurology. 2020.Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Papadopoulou A; Oertel FC; Gaetano L; Kuchling J; Zimmermann H; Chien C; Siebert N; Asseyer S; Bellmann-Strobl J; Ruprecht K; Chakravarty MM; Scheel M; Magon S; Wuerfel J; Paul F; Brandt AU. Journal of Neurology, Neurosurgery and Psychiatry. 2019.Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
Papadopoulou A; Gaetano L; Pfister A; Altermatt A; Tsagkas C; Morency F; Brandt AU; Hardmeier M; Chakravarty MM; Descoteaux M; Kappos L; Sprenger T; Magon S. Neurology. 2019.Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.
Nolan-Kenney RC; Liu M; Akhand O; Calabresi PA; Paul F; Petzold A; Balk L; Brandt AU; Martínez-Lapiscina EH; Saidha S; Villoslada P; Al-Hassan AA; Behbehani R; Frohman EM; Frohman T; Havla J; Hemmer B; Jiang H; Knier B; Korn T; Leocani L; Papadopoulou A; Pisa M; Zimmermann H; Galetta SL; Balcer LJ; International Multiple Sclerosis Visual System Consortium. Annals of Neurology. 2019.[Optical Coherence Tomography in Disorders of the Central Nervous System].
Papadopoulou A; Oertel FC; Zimmermann H; Zeitz O; Brandt AU; Paul F. Klinische Monatsblatter fur Augenheilkunde. 2018.Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.
Seifert CL; Schönbach EM; Zimmer C; Förschler A; Tölle TR; Feurer R; Gempt J; Papadopoulou A; Magon S; Sprenger T; Poppert H. Cephalalgia. 2018.Cortical Thickness Alterations in Chronic Pain Disorder: An Exploratory MRI Study.
Magon S; Sprenger T; Otti A; Papadopoulou A; Gündel H; Noll-Hussong M. Psychosomatic Medicine. 2018.Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial.
Hanssen H; Minghetti A; Magon S; Rossmeissl A; Rasenack M; Papadopoulou A; Klenk C; Faude O; Zahner L; Sprenger T; Donath L. Scandinavian journal of medicine & science in sports. 2018.Unilateral leg oedema due to spontaneous Achilles tendon rupture.
Papadopoulou A; Kronlage C; Kampmann M; Budweg J. Oxford medical case reports. 2018.Daclizumab for the treatment of multiple sclerosis.
Papadopoulou A; Derfuss T; Sprenger T. Neurodegenerative disease management. 2017.Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.
D'Souza M; Yaldizli Ö; John R; Vogt DR; Papadopoulou A; Lucassen E; Menegola M; Andelova M; Dahlke F; Schnyder F; Kappos L. Multiple sclerosis (Houndmills, Basingstoke, England). 2017.Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial.
Hanssen H; Minghetti A; Magon S; Rossmeissl A; Papadopoulou A; Klenk C; Schmidt-Trucksäss A; Faude O; Zahner L; Sprenger T; Donath L. Frontiers in physiology. 2017.Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.
Andermatt S; Papadopoulou A; Radue EW; Sprenger T; Cattin P. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2017.Decision for intravenous thrombolysis in a young patient with acute vertical gaze palsy.
Papadopoulou A; Ahlhelm FJ; Lyrer P; Kuhle J. ACTA NEUROLOGICA BELGICA. 2015.Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis.
Amann M; Papadopoulou A; Andelova M; Magon S; Mueller-Lenke N; Naegelin Y; Stippich C; Radue EW; Bieri O; Kappos L; Sprenger T. Journal of Neurology. 2015.Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis.
Papadopoulou A; Kappos L; Sprenger T. Expert opinion on drug safety. 2015.Intrathecal gadolinium for magnetic resonance myelography in spontaneous intracranial hypotension: valuable but may be risky--reply.
Papadopoulou A; Ahlhelm FJ; Sprenger T. JAMA neurology. 2014.Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Papadopoulou A; Menegola M; Kuhle J; Ramagopalan SV; D'Souza M; Sprenger T; Radue EW; Kappos L; Yaldizli Ö. Multiple sclerosis (Houndmills, Basingstoke, England). 2014.MRI characteristics of periaqueductal lesions in multiple sclerosis.
Papadopoulou A; Naegelin Y; Weier K; Amann M; Hirsch J; von Felten S; Yaldizli O; Sprenger T; Radue EW; Kappos L; Gass A. Multiple Sclerosis and Related Disorders. 2014.The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A. Multiple sclerosis (Houndmills, Basingstoke, England). 2014.Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis
Papadopoulou A.; Muller-Lenke N.; Naegelin Y.; Kalt G.; Bendfeldt K.; Kuster P.; Stoecklin M.; Gass A.; Sprenger T.; Radue E.W.; Kappos L.; Penner I.-K.. Multiple sclerosis (Houndmills, Basingstoke, England). 2013.Detection of cerebrospinal fluid leaks by intrathecal contrast-enhanced magnetic resonance myelography.
Papadopoulou A; Ahlhelm FJ; Ulmer S; Kappos L; Sprenger T. JAMA neurology. 2013.Evolution of MS lesions to black holes under DNA vaccine treatment.
Papadopoulou A; von Felten S; Traud S; Rahman A; Quan J; King R; Garren H; Steinman L; Cutter G; Kappos L; Radue EW. Journal of Neurology. 2012.Teriflunomide for oral therapy in multiple sclerosis.
Papadopoulou A; Kappos L; Sprenger T. Expert Review of Clinical Pharmacology. 2012.Fatigue and progression of corpus callosum atrophy in multiple sclerosis.
Yaldizli Ö; Glassl S; Sturm D; Papadopoulou A; Gass A; Tettenborn B; Putzki N. Journal of Neurology. 2011.Dimethyl fumarate for multiple sclerosis.
Papadopoulou A; D'Souza M; Kappos L; Yaldizli O. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2010.Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW; Stuart WH; Calabresi PA; Confavreux C; Galetta SL; Rudick RA; Lublin FD; Weinstock-Guttman B; Wynn DR; Fisher E; Papadopoulou A; Lynn F; Panzara MA; Sandrock AW; SENTINEL Investigators. Journal of the neurological sciences. 2010.